Joseph M. Jacob

Disclosure information not submitted.

Presentation(s):

• PD24-07: First Analysis of the Safety and Efficacy of UGN-101 in the Treatment of Ureteral Tumors

  Sunday, April 30, 2023
  8:00 AM – 8:10 AM CST